MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.leukres.2010.05.003

Медицинская библиотека · Leukemia research · 2010

The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.

Dmoszynska Anna, Walter-Croneck Adam, Hus Iwona, Grzasko Norbert, Manko Joanna, Jedrzejczak Wieslaw Wiktor, Charlinski Grzegorz, Usnarska-Zubkiewicz Lidia, Skotnicki Aleksander, Wolska-Smolen Teresa, Piszcz Jaroslaw, Kloczko Janusz

СтатьяМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

Multiple myeloma (MM) remains an incurable disease, but response rates to new drugs are promising, offering the majority of patients a significant prolongation of overall survival. The objective of this study was to evaluate time to progression (TTP), event-free survival (EFS), and overall survival (OS) in MM patients treated with a combination of cyclophosphamide (CY), thalidomide (THAL) and dexamethasone (DEX). This study included 132 untreated and relapsing/resistant patients treated with the low-thalidomide dose CTD regimen. The patients received CY 500 mg/m(2)i.v. or 625 mg/m(2) orally at day 1, THAL 100mg/day á la longue and DEX 20mg/day at days 1-4 and 8-11, every 28 days. Patients received 6-9 cycles; ORR by 3 months was 59.1%, by 6 months 65.6% and by 9 months 75.6%. In patients responding to CTD therapy (CR, nCR, PR), the probability of survival for 20 months was 89.3%. The outpatient low-thalidomide dose CTD regimen is well tolerated and produces a significant response rate both in untreated and relapsing/resistant MM patients.

Для цитирования: Dmoszynska Anna, Walter-Croneck Adam, Hus Iwona, Grzasko Norbert, Manko Joanna, Jedrzejczak Wieslaw Wiktor, Charlinski Grzegorz, Usnarska-Zubkiewicz Lidia, Skotnicki Aleksander, Wolska-Smolen Teresa, Piszcz Jaroslaw, Kloczko Janusz. The efficacy and safety of the low-thalidomide dose CTD (cyclophosphamide, thalidomide, dexamethasone) regimen in patients with multiple myeloma--a report by the Polish Myeloma Study Group.. Leukemia research. 2010. DOI: 10.1016/j.leukres.2010.05.003.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.